VAERS Explorer
Back to explore

Report #2832749

Received Mar 24, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Male
Age
Age unknown
State
—
Recovered
Unknown
Vaccinated
—
Onset
—
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
VARZOSZOSTER (SHINGRIX)GLAXOSMITHKLINE BIOLOGICALS1UNK—

Symptoms (2)

Herpes zosterIncomplete course of vaccination

Symptom narrative

Breakthrough herpes zoster; This non-serious case was reported by a nurse via sales rep and described the occurrence of herpes zoster in a male patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingrix (unknown arm). On an unknown date, an unknown time after receiving Shingrix, the patient experienced herpes zoster (Verbatim: Breakthrough herpes zoster). The outcome of the herpes zoster was unknown. The reporter considered the herpes zoster to be related to Shingrix. The company considered the herpes zoster to be related to Shingrix. Additional Information: GSK Receipt Date: 12-MAR-2025 The patient received the shingrix first dose and experienced breakthrough herpes zoster. Patient received first dose of Shingrix and did not go back for second dose. Patient had breakthrough case of shingles after receiving only one dose.